Clinical trial

Effects of Antidiabetic Medications on the Postprandial State in Prediabetes

NCT02104739

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-04-01

PhasePHASE4

Study timeline

Study start (actual)2014-04-01Date precision: month

Registry last updated2018-07-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prediabetesunresolved

Obesityunresolved

Interventions

ExenatideDRUG · verified · RxNorm: exenatide

SaxagliptinDRUG · verified · RxNorm: saxagliptin

Exenatide extended-release (ER)DRUG

Sponsors & collaborators

The University of Texas Health Science Center, Houstonlead sponsor

The Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houstoncollaborator

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02104739 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.